Outcome | Pre-treatment | Post-treatment | 6-mo f-u | Pre-to post-treatment comparison | Post- to 6-mo follow-up comparison | Pre-to 6-mo follow-up comparison | |||
---|---|---|---|---|---|---|---|---|---|
Count- data | Median (IQR) | Median (IQR) | Median (IQR) | Z | Percentage change [95% CI] | Z | Percentage change [95% CI] | Z | Percentage change [95% CI] |
DSHI-9-f | 8 (4 to 13) | 2.5 (0 to 4.25) | 0 (0 to 3) | 2.33* | 42 [8 to 64] | 3.82*** | 63 [39 to 78] | 4.77*** | 79 [60 to 89] |
BSL | 3 (2 to 3) | 1 (0 to 3) | 1 (0 to 2.75) | 2.16* | 44 [5 to 67] | 0.35 | 13 [−91 to 60] | 1.99* | 52 [1 to 76] |
Continuous | Mean (SD) | Mean (SD) | Mean (SD) | Z | Cohen’s d [95% CI] | Z | Cohen’s d [95% CI] | Z | Cohen’s d [95% CI] |
DSHI-9-v | 2.12 (1.54) | 1.35 (1.22) | 0.80 (1.01) | 2.02* | 0.50 [0.07 to 0.78] | 2.24* | 0.40 [0.09 to 0.80] | 2.61** | 0.89 [0.47 to 1.23] |
DERS | 122.71 (17.18) | 109.69 (25.21) | 100.57 (17.89) | 2.91** | 0.81 [0.23 to 1.50] | 2.66** | 0.59 [0.15 to 1.05] | 4.44*** | 1.40 [0.87 to 2.03] |
BPFSC | 70.35 (10.72) | 66.88 (12.61) | 63.36 (11.34) | 1.45 | 0.33 [−0.03 to 1.11] | 1.47 | 0.36 [−0.16 to 0.87] | 2.73** | 0.69 [0.18 to 1.19] |
CGAS | 51.24 (4.94) | 56.59 (7.97) | 61.07 (11.21) | 3.7*** | 1.08 [0.51 to 1.62] | 1.72 | 0.85 [−0.22 to 2.13] | 4.74*** | 1.94 [1.03 to 3.12] |